(19)
(11) EP 0 391 953 A1

(12)

(43) Date of publication:
17.10.1990 Bulletin 1990/42

(21) Application number: 89900553.0

(22) Date of filing: 01.12.1988
(51) International Patent Classification (IPC): 
C12N 15/ 09( . )
A61K 38/ 55( . )
A61P 25/ 04( . )
C07K 1/ 22( . )
C07K 7/ 08( . )
C07K 16/ 30( . )
C12N 5/ 10( . )
C12N 9/ 64( . )
A61K 38/ 00( . )
A61K 39/ 00( . )
A61P 35/ 02( . )
C07K 7/ 06( . )
C07K 14/ 00( . )
C07K 16/ 40( . )
C12N 7/ 00( . )
(86) International application number:
PCT/US1988/004280
(87) International publication number:
WO 1989/005353 (15.06.1989 Gazette 1989/13)
(84) Designated Contracting States:
AT BE CH DE FR GB IT LI LU NL SE

(30) Priority: 04.12.1987 US 19870128630
22.09.1988 US 19880247915

(71) Applicant: DANA FARBER CANCER INSTITUTE
Boston Massachusetts 02115 (US)

(72) Inventors:
  • REINHERZ, Ellis L.
    Lincoln, MA 01773 (US)
  • SHIPP, Margaret A.
    Wellesley, MA 02181 (US)
  • RICHARDSON, Neil E.
    deceased (US)
  • RITZ, Jerome
    Lincoln, MA 01773 (US)
  • SAYRE, Peter H.
    New Brunswick, NJ 08901 (US)

(74) Representative: Holdcroft, James Gerald, Dr., et al 
Graham Watt & Co., Riverhead
Sevenoaks, Kent TN13 2BN
Sevenoaks, Kent TN13 2BN (GB)

   


(54) COMMON ACUTE LYMPHOBLASTIC LEUKEMIA ANTIGEN